Literature DB >> 28575679

Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.

Roel Nusse1, Hans Clevers2.   

Abstract

The WNT signal transduction cascade is a main regulator of development throughout the animal kingdom. Wnts are also key drivers of most types of tissue stem cells in adult mammals. Unsurprisingly, mutated Wnt pathway components are causative to multiple growth-related pathologies and to cancer. Here, we describe the core Wnt/β-catenin signaling pathway, how it controls stem cells, and contributes to disease. Finally, we discuss strategies for Wnt-based therapies.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Wnt; cancer; development; stem cells; therapy

Mesh:

Substances:

Year:  2017        PMID: 28575679     DOI: 10.1016/j.cell.2017.05.016

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  1125 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

Review 2.  Regulation of Wnt signaling by protocadherins.

Authors:  Kar Men Mah; Joshua A Weiner
Journal:  Semin Cell Dev Biol       Date:  2017-08-01       Impact factor: 7.727

3.  Intersection of two key signal integrators in the cell: activator of G-protein signaling 3 and dishevelled-2.

Authors:  Ali Vural; Stephen M Lanier
Journal:  J Cell Sci       Date:  2020-09-04       Impact factor: 5.285

4.  Limited dishevelled/Axin oligomerization determines efficiency of Wnt/β-catenin signal transduction.

Authors:  Wei Kan; Michael D Enos; Elgin Korkmazhan; Stefan Muennich; Dong-Hua Chen; Melissa V Gammons; Mansi Vasishtha; Mariann Bienz; Alexander R Dunn; Georgios Skiniotis; William I Weis
Journal:  Elife       Date:  2020-04-16       Impact factor: 8.140

5.  YTHDF1-mediated translation amplifies Wnt-driven intestinal stemness.

Authors:  Bing Han; Sujun Yan; Saisai Wei; Jie Xiang; Kangli Liu; Zhanghui Chen; Rongpan Bai; Jinghao Sheng; Zhengping Xu; Xiangwei Gao
Journal:  EMBO Rep       Date:  2020-02-17       Impact factor: 8.807

Review 6.  A regulatory loop connecting WNT signaling and telomere capping: possible therapeutic implications for dyskeratosis congenita.

Authors:  Rafael Jesus Fernandez; F Brad Johnson
Journal:  Ann N Y Acad Sci       Date:  2018-04       Impact factor: 5.691

7.  The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes.

Authors:  Tina Hörbelt; Christopher Tacke; Mariya Markova; Daniella Herzfeld de Wiza; Frederique Van de Velde; Marlies Bekaert; Yves Van Nieuwenhove; Silke Hornemann; Maria Rödiger; Nicole Seebeck; Elisabeth Friedl; Wenke Jonas; G Hege Thoresen; Oliver Kuss; Anke Rosenthal; Volker Lange; Andreas F H Pfeiffer; Annette Schürmann; Bruno Lapauw; Natalia Rudovich; Olga Pivovarova; D Margriet Ouwens
Journal:  Diabetologia       Date:  2018-05-12       Impact factor: 10.122

8.  R-spondin3-LGR4 signaling protects hepatocytes against DMOG-induced hypoxia/reoxygenation injury through activating β-catenin.

Authors:  Shiying Liu; Yue Yin; Ruili Yu; Yin Li; Weizhen Zhang
Journal:  Biochem Biophys Res Commun       Date:  2018-03-19       Impact factor: 3.575

9.  Mechanistic basis and efficacy of targeting the β-catenin-TCF7L2-JMJD6-c-Myc axis to overcome resistance to BET inhibitors.

Authors:  Dyana T Saenz; Warren Fiskus; Christopher P Mill; Dimuthu Perera; Taghi Manshouri; Bernardo H Lara; Vrajesh Karkhanis; Sunil Sharma; Stephen K Horrigan; Prithviraj Bose; Tapan M Kadia; Lucia Masarova; Courtney D DiNardo; Gautam Borthakur; Joseph D Khoury; Koichi Takahashi; Srividya Bhaskara; Charles Y Lin; Michael R Green; Cristian Coarfa; Craig M Crews; Srdan Verstovsek; Kapil N Bhalla
Journal:  Blood       Date:  2020-04-09       Impact factor: 22.113

Review 10.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.